你目前无法使用部分二次筛选功能
请联系客服开通更多权限和功能!
申请号 | 产品号 | 商品名 | 活性成分 | 活性成分 | 剂型/给药途径 | 规格/剂量 | 申请机构 | 批准时间 | 参比制剂 | 标准制剂 | 市场状态 | TE |
---|---|---|---|---|---|---|---|---|---|---|---|---|
(NDA) 019593 | 002 | ZANTAC IN PLASTIC CONTAINER | RANITIDINE HYDROCHLORIDE | 盐酸雷尼替丁 | INJECTABLE;INJECTION | EQ 1MG BASE/ML | PAI HOLDINGS PHARM | 1991-09-27 | No | No | DISCN | |
(NDA) 019593 | 001 | ZANTAC IN PLASTIC CONTAINER | RANITIDINE HYDROCHLORIDE | 盐酸雷尼替丁 | INJECTABLE;INJECTION | EQ 50MG BASE/100ML | PAI HOLDINGS PHARM | 1986-12-17 | No | No | DISCN | |
(NDA) 020520 | 001 | ZANTAC 75 | RANITIDINE HYDROCHLORIDE | 盐酸雷尼替丁 | TABLET;ORAL | EQ 75MG BASE | CHATTEM SANOFI | 1995-12-19 | Yes | No | DISCN | |
(NDA) 020745 | 001 | ZANTAC 75 | RANITIDINE HYDROCHLORIDE | 盐酸雷尼替丁 | TABLET, EFFERVESCENT;ORAL | EQ 75MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | CHATTEM SANOFI | 1998-02-26 | Yes | No | DISCN | |
(NDA) 018703 | 002 | ZANTAC 300 | RANITIDINE HYDROCHLORIDE | 盐酸雷尼替丁 | TABLET;ORAL | EQ 300MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | GLAXO GRP LTD | 1985-12-09 | Yes | No | DISCN | |
(NDA) 020095 | 002 | ZANTAC 300 | RANITIDINE HYDROCHLORIDE | 盐酸雷尼替丁 | CAPSULE;ORAL | EQ 300MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | GLAXOSMITHKLINE | 1994-03-08 | Yes | No | DISCN | |
(NDA) 020251 | 003 | ZANTAC 25 | RANITIDINE HYDROCHLORIDE | 盐酸雷尼替丁 | TABLET, EFFERVESCENT;ORAL | EQ 25MG BASE | GLAXO GRP LTD | 2004-04-01 | No | No | DISCN | |
(NDA) 020095 | 001 | ZANTAC 150 | RANITIDINE HYDROCHLORIDE | 盐酸雷尼替丁 | CAPSULE;ORAL | EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | GLAXOSMITHKLINE | 1994-03-08 | Yes | No | DISCN | |
(NDA) 020251 | 002 | ZANTAC 150 | RANITIDINE HYDROCHLORIDE | 盐酸雷尼替丁 | GRANULE, EFFERVESCENT;ORAL | EQ 150MG BASE/PACKET | GLAXO GRP LTD | 1994-03-31 | No | No | DISCN | |
(NDA) 021698 | 002 | ZANTAC 150 | RANITIDINE HYDROCHLORIDE | 盐酸雷尼替丁 | TABLET;ORAL | EQ 150MG BASE | CHATTEM SANOFI | 2007-03-13 | Yes | No | DISCN | |
(NDA) 020251 | 001 | ZANTAC 150 | RANITIDINE HYDROCHLORIDE | 盐酸雷尼替丁 | TABLET, EFFERVESCENT;ORAL | EQ 150MG BASE | GLAXO GRP LTD | 1994-03-31 | No | No | DISCN | |
(NDA) 021698 | 001 | ZANTAC 150 | RANITIDINE HYDROCHLORIDE | 盐酸雷尼替丁 | TABLET;ORAL | EQ 150MG BASE | CHATTEM SANOFI | 2004-08-31 | Yes | No | DISCN | |
(NDA) 018703 | 001 | ZANTAC 150 | RANITIDINE HYDROCHLORIDE | 盐酸雷尼替丁 | TABLET;ORAL | EQ 150MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | GLAXO GRP LTD | 1983-06-09 | Yes | No | DISCN | |
(NDA) 019675 | 001 | ZANTAC | RANITIDINE HYDROCHLORIDE | 盐酸雷尼替丁 | SYRUP;ORAL | EQ 15MG BASE/ML | GLAXO GRP LTD | 1988-12-30 | Yes | No | DISCN | |
(NDA) 019090 | 001 | ZANTAC | RANITIDINE HYDROCHLORIDE | 盐酸雷尼替丁 | INJECTABLE;INJECTION | EQ 25MG BASE/ML | PAI HOLDINGS PHARM | 1984-10-19 | Yes | No | DISCN | |
(ANDA) 075557 | 001 | RANITIDINE HYDROCHLORIDE | RANITIDINE HYDROCHLORIDE | 盐酸雷尼替丁 | CAPSULE;ORAL | EQ 150MG BASE | TEVA | 2003-10-31 | No | No | DISCN | |
(ANDA) 074655 | 002 | RANITIDINE HYDROCHLORIDE | RANITIDINE HYDROCHLORIDE | 盐酸雷尼替丁 | CAPSULE;ORAL | EQ 300MG BASE | SANDOZ | 1997-10-22 | No | Yes | RX | AB |
(ANDA) 074655 | 001 | RANITIDINE HYDROCHLORIDE | RANITIDINE HYDROCHLORIDE | 盐酸雷尼替丁 | CAPSULE;ORAL | EQ 150MG BASE | SANDOZ | 1997-10-22 | No | No | RX | AB |
(ANDA) 075742 | 001 | RANITIDINE HYDROCHLORIDE | RANITIDINE HYDROCHLORIDE | 盐酸雷尼替丁 | CAPSULE;ORAL | EQ 150MG BASE | DR REDDYS LABS LTD | 2000-11-29 | No | No | RX | AB |
(ANDA) 211058 | 002 | RANITIDINE HYDROCHLORIDE | RANITIDINE HYDROCHLORIDE | 盐酸雷尼替丁 | CAPSULE;ORAL | EQ 300MG BASE | AUROBINDO PHARMA | 2018-07-16 | No | No | DISCN |